Format

Send to

Choose Destination

ALSFRS-R.

Author information

1
Eleanor and Lou Gehrig MDA/ALS Research Center, Neurological Institute, New York, NY 10032, USA. pgordon@neuro.columbia.edu

Abstract

The ALSFRS-R is an attractive primary outcome measure in clinical trials of ALS because it is validated, easy to administer, minimizes dropout, reduces cost, and correlates with survival. Unlike the other standard outcome measures currently employed, the ALSFRS-R is also a measure of global function.

PMID:
15512883
DOI:
10.1080/17434470410019906
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center